Obesity is an alarming disease that favors the upset of other illnesses and enhances
mortality. It is spreading fast worldwide may affect more than 1 billion people by 2030. The …

Dietary habits in the western world lead to increasing phosphate intake. Under physiological
conditions, extraosseous precipitation of phosphate with calcium is prevented by a mineral …

The bone-derived hormone fibroblast growth factor 23 (FGF23) acts in concert with
parathyroid hormone (PTH) and the active vitamin D metabolite calcitriol in the regulation of …

Fibroblast growth factor 23 (FGF23) has been described as an important regulator of mineral
homeostasis, but has lately also been linked to iron deficiency, inflammation, and …

Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone produced mainly in
osteocytes. In chronic kidney disease (CKD) FGF23 levels increase due to higher …

Background: In acute kidney injury (AKI), plasma fibroblast growth factor 23 (FGF23) and
phosphate (P i) rise rapidly and are independently associated with disease severity and …

Iron deficiency is a potent stimulator of fibroblast growth factor 23 (FGF23), a hormonal
regulator of phosphate and vitamin D metabolism, that is classically thought to be produced …

Diabetes affects about 422 million people worldwide, causing 1.5 million deaths each year.
However, the incidence of diabetes is increasing, including several types of diabetes. Type 1 …

Cardiovascular disease and mineral bone disorders are major contributors to morbidity and
mortality among patients with chronic kidney disease and often persist after renal …

Aging is an inevitable biological process, and longevity may be related to bone health.
Maintaining strong bone health can extend one's lifespan, but the exact mechanism is …